Salisbury, MD, United States of America

Jose Juncosa


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jose Juncosa

Introduction

Jose Juncosa is a notable inventor based in Salisbury, MD (US), recognized for his significant contributions to the field of pharmaceutical chemistry. He holds three patents that focus on the development of compounds aimed at treating various neurological disorders and diseases.

Latest Patents

Juncosa's latest patents include the invention of 3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds, which serve as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase. These cyclopentene compounds are designed for use in pharmaceutical compositions to treat diseases associated with GABA-AT and ornithine aminotransferase (OAT) activity, including epilepsy, addiction, and hepatocellular carcinoma (HCC). Another significant patent involves (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, which acts as a GABA aminotransferase inactivator for the treatment of similar conditions.

Career Highlights

Jose Juncosa is affiliated with Northwestern University, where he continues to advance research in the field of medicinal chemistry. His work has led to the development of innovative compounds that have the potential to improve treatment options for patients suffering from various neurological disorders.

Collaborations

Throughout his career, Juncosa has collaborated with esteemed colleagues such as Richard B Silverman and Kenji Takaya. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Jose Juncosa's contributions to the field of pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…